Page last updated: 2024-11-06

2-(methylamino)isobutyric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-(Methylamino)isobutyric acid (MeAib) is a non-proteinogenic amino acid that has been studied for its unique structural and biological properties. MeAib can be synthesized via several methods, including the reaction of isobutyric acid with methylamine. It is often used as a structural mimic of valine in peptides due to its similar size and hydrophobic nature. MeAib has been found to enhance the stability and helical structure of peptides. It also exhibits interesting biological effects, including anti-inflammatory and anticancer properties. MeAib is studied for its potential applications in drug development and peptide engineering.'

alpha-(methylamino)isobutyric acid : A non-proteinogenic alpha-amino acid that is isobutyric acid in which the alpha-hydrogen has been replaced by a methylamino group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID75725
CHEMBL ID1916079
CHEBI ID134261
SCHEMBL ID141814
MeSH IDM0069041

Synonyms (49)

Synonym
alpha-methylaminoisobutyrate
alpha-(methylamino)isobutyrate
n-(methylamino)isobutyric acid
einecs 219-898-2
unii-26f96c8mbj
alpha-(methylamino)-isobutyric acid
26f96c8mbj ,
alpha-(methylamino)isobutyric acid, >=97% (titration)
meaib
2-(methylamino)isobutyric acid
CHEBI:134261
alpha-(methylamino)isobutyric acid
2566-34-9
2-methyl-2-(methylamino)propanoic acid
2-methyl-3-methylaminopropanoic acid
dlamvqgyevkire-uhfffaoysa-
inchi=1/c5h11no2/c1-5(2,6-3)4(7)8/h6h,1-3h3,(h,7,8)
M1388
n,2-dimethylalanine
AKOS005363208
2-methyl-2-methylaminopropanoic acid
2-(methylamino)isobutyric acid hydrate
n-methylaminoisobutyric acid
CHEMBL1916079 ,
bdbm50357217
FT-0634370
2-(methylamino)-2-methylpropionic acid
alanine, n,2-dimethyl-
gtpl4697
SCHEMBL141814
.alpha.-(methylamino)isobutyric acid
n-methyl-.alpha.-aminoisobutyric acid
DTXSID90180360
n-methyl-a-aminoisobutyric acid
n-methyl-alpha-aminoisobutyrate
AS-63651
methylaminoisobutyric acid
A930307
alanine,n,2-dimethyl-
Q27083887
n-methyl-alpha-aminoisobutyric acid
n-methyl-a-aminoisobutyrate
h-meaib-oh
2-(n-methylamino)isobutyric acid
EN300-65657
T72178
n,2-dimethyl-dl-alanine
HY-134452
CS-0142453

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Likewise, the insulin dose-response relationship confirmed that physiological levels of insulin (less than or equal to 10(2) microU/ml) increased transport by a similar degree."( System A amino acid transport in incubated muscle: effects of insulin and acute uremia.
Karapanos, G; Maroni, BJ; Mitch, WE, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human urinary metaboliteAny metabolite (endogenous or exogenous) found in human urine samples.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
alanine derivativeAn amino acid derivative resulting from reaction of alanine at the amino group or the carboxy group, or from the replacement of any hydrogen of alanine by a heteroatom. The definition normally excludes peptides containing alanine residues.
non-proteinogenic alpha-amino acidAny alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
secondary amino compoundA compound formally derived from ammonia by replacing two hydrogen atoms by organyl groups.
alpha-amino acid zwitterionAn amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of any alpha-amino acid; major species at pH 7.3.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (10)

Processvia Protein(s)Taxonomy
monoatomic ion transportProton-coupled amino acid transporter 1Homo sapiens (human)
amino acid transportProton-coupled amino acid transporter 1Homo sapiens (human)
taurine transmembrane transportProton-coupled amino acid transporter 1Homo sapiens (human)
proline transportProton-coupled amino acid transporter 1Homo sapiens (human)
alanine transportProton-coupled amino acid transporter 1Homo sapiens (human)
amino acid import across plasma membraneProton-coupled amino acid transporter 1Homo sapiens (human)
glycine transportProton-coupled amino acid transporter 1Homo sapiens (human)
proline transmembrane transportProton-coupled amino acid transporter 1Homo sapiens (human)
proton transmembrane transportProton-coupled amino acid transporter 1Homo sapiens (human)
L-alanine transportProton-coupled amino acid transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (9)

Processvia Protein(s)Taxonomy
amino acid:proton symporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
proline:proton symporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
taurine transmembrane transporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
protein bindingProton-coupled amino acid transporter 1Homo sapiens (human)
amino acid transmembrane transporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
alanine transmembrane transporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
L-alanine transmembrane transporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
L-proline transmembrane transporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
glycine transmembrane transporter activityProton-coupled amino acid transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
lysosomal membraneProton-coupled amino acid transporter 1Homo sapiens (human)
endoplasmic reticulumProton-coupled amino acid transporter 1Homo sapiens (human)
plasma membraneProton-coupled amino acid transporter 1Homo sapiens (human)
apical plasma membraneProton-coupled amino acid transporter 1Homo sapiens (human)
vacuolar membraneProton-coupled amino acid transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID630741Inhibition of human PAT1-mediated L-[3H]proline uptake in human Caco2 cells after 10 mins by liquid scintillation counting2011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Three-dimensional quantitative structure-activity relationship analyses of substrates of the human proton-coupled amino acid transporter 1 (hPAT1).
AID681145TP_TRANSPORTER: uptake in Xenopus laevis oocytes2002Genomics, Jan, Volume: 79, Issue:1
The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (168)

TimeframeStudies, This Drug (%)All Drugs %
pre-199099 (58.93)18.7374
1990's44 (26.19)18.2507
2000's19 (11.31)29.6817
2010's6 (3.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 8.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index8.90 (24.57)
Research Supply Index5.16 (2.92)
Research Growth Index4.06 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (8.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.15%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other172 (98.85%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]